Triglyceride levels were measured and normalized to protein in whole animal lysates of mid-third instar larvae expressing the following transgenes in fat body under control of r4-GAL4: A) GFP, Toll 10b , Dilp2, or Toll 10b + Dilp2, n = 6-14/gp, except GFP, n = 34, ****p < 0.0001 and ***p = 0.0002 versus GFP; B) GFP, Toll 10b , InR A1325 , or InR A1325 + Toll 10b , n = 10-13/gp, except GFP, n = 33, **p = 0.0013 and ****p < 0.0001 versus GFP; C) RFP + GFP, Toll 10b + GFP, RFP + myrAkt, or Toll 10b + myrAkt, n = 20-23/gp, *p = 0.0207 versus RFP+GFP. Data are presented as mean ± S.D. RNA was isolated from mid-third instar larval fat bodies expressing GFP or Toll 10b under control of r4-GAL4. Transcript levels of InR, chico, PI3K92E (encodes Dp110), Pten, Pdk1, Akt1, rictor, Tor, Phlpp and Drs were measured in equal amounts of cDNA by Q-PCR. All transcripts are normalized to Rp49 levels, which did not differ between genotypes. Drs encodes Drosomycin, a canonical antimicrobial peptide target gene of the Toll signaling pathway. *p < 0.05, **p < 0.01 and ****p < 0.0001 versus GFP, n = 6-7 samples/genotype. Data are presented as mean ± S.D. , or Pdk1 myc8 (n = 2 flies/lane) and E) larval fat bodies heterozygous for Pdk1 myc1 and expressing GFP or a Pdk1
RNAi transgene under control of the fat body driver r4-GAL4 (n = 3/gp, 10 fat bodies pooled/lane). 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES

Drosophila stocks used in this study
The following stocks obtained from the Bloomington Drosophila Stock Center (Bloomington, IN, NIH P40OD018537) were used in this study: UAS-InR A1325D (#8263), UAS-Dp110 CAAX (#25908), UAS-RFP (#30556), UAS-GFP (2nd (#1521) and 3rd (#1522) chromosome insertions), UAS-Dif RNAi (#30513), UAS-Pdk1 RNAi (#27725), hsFLP22 (#8862), Act5c>Cd2>Gal4 (#4780), tGPH (#8163), r4-GAL4 (#33832). Other flies used were: UAS-Toll 10b (Hu et al., 2004) , rictor Δ 2 (Hietakangas and Cohen, 2007) , UAS-Akt1.HA (wild type) and UAS-myrAkt (Verdu et al., 1999) , and Pdk1 Δ 33 (Cheng et al., 2011) .
Construction of UAS-Akt T342D and UAS-Pdk1 transgenic flies For UAS-Akt
T342D and UAS-Pdk1 transgenes, full-length cDNAs (Akt: clone SD10374 and Pdk1: clone LD22131 (836 aa isoform), Drosophila Genomics Resource Center, Bloomington, IN, NIH 2P40OD010949) were amplified with gene-specific primers engineered to contain carboxy-terminal HA (Akt) or myc (Pdk1) tags. PCR products were cloned into pENTR (Invitrogen), and phosphorylation site mutations (including phospho-mimicking T342D) were introduced by site-directed mutagenesis (Q5 kit, New England Biolabs). Primer sequences used for cloning and site-directed mutagenesis are listed at the end of this section. Gateway cloning (Invitrogen) was used to generate pUASTAkt T342D .HA and pUAST-Pdk1.myc. Transgene constructs were injected into Drosophila embryos at Rainbow Transgenics (Camarillo, CA). Standard genetics was used to map and generate balanced transgenic lines.
Construction of a myc-tagged
Pdk1 allele CRISPR/Cas9 was used to insert a myc epitope tag at the 3' end of the final coding exon of Pdk1, which is common to all splice variants. The Fly CRISPR Optimal Target Finder (Gratz et al., 2014) was used to identify a CRISPR target site located just upstream of the Pdk1 stop codon ( Figure S4A ,B) and with only one predicted off-target site on the X chromosome (Pdk1 is on chromosome 3). Oligos encoding the Pdk1 CRISPR-targeting RNA were annealed and ligated into the BbsI site of pU6-BbsI-chiRNA, and PCR was used to create the template for in vitro transcription of the gRNA using the MEGAscript T7 kit (Ambion). The donor template for homology-directed repair consisted of a 200 nucleotide ssDNA oligo with 79 and 81 nt left and right homology arms flanking the myc epitope tag coding sequence, which was engineered immediately 5' of the Pdk1 stop codon. The PAM sequence of the gRNA binding site in the donor template was mutated, and two additional stop codons in the two alternate reading frames were added downstream of the original stop codon ( Figure S4B ). Oligonucleotide sequences are listed at the end of this section. See Supplementary Figure 4 for further details.
The gRNA and ssDNA donor template (synthesized as a PAGE-Purified Ultramer by Integrated DNA Technologies, Coralville, IA) were analyzed by separation on a 10% TBE-Urea gel (Bio-Rad) and found to be intact and full-length. The gRNA and ssDNA donor template were injected into nos-Cas9/CyO embryos at Rainbow Transgenics (Camarillo, CA). Standard fly genetics was used to balance putative insertion lines and to remove nos-Cas9. Out of 120 injected embryos, 35 F0 flies were fertile, and eight F1 lines were established for each fertile F0 line. The F1 lines were screened by Western blotting for the myc epitope tag, and four F0 lines bearing the insertion were identified. PCR-based genotyping and sequencing were carried out on each of these four lines to validate insertions ( Figure S4C) . Insertion lines were further tested by Western blotting to assess: 1) dose-dependent increase in myc-tag signal in Pdk1 myc /+ compared with Pdk1 myc /Pdk1 myc animals ( Figure S4D ) and 2) elimination of myc-tag signal in fat body lysates from larvae expressing UAS-Pdk1
RNAi under control of r4-GAL4 ( Figure S4E ). We noted no fertility, viability or growth defects in flies heterozygous or homozygous for Pdk1 myc alleles compared with wild type, suggesting that the myc insertion has negligible effect on Pdk1 function. We also noted that both fat body and whole animal-lysates show that the major Pdk1 splice variant expressed in larvae is the 755 aa (85.6 kDa) form rather than the 539 or 836 aa forms (61 or 94.1 kDa). The Pdk1 myc1 allele was used for protein expression experiments in Figure 3 .
Whole-mount Immunocytochemistry
Fat bodies bearing clones of cells expressing UAS-transgenes, generated using the FLP; Act5c>Cd2>GAL4 system (Pignoni and Zipursky, 1997) , were dissected from mid-third instar larvae. Fat bodies were fixed in 4% paraformaldehyde for 20 min, blocked in 10% normal donkey and goat sera (Jackson ImmunoResearch) in PBS with 0.1% Triton X-100 (10% ND/GS-T) for 30 min, then incubated overnight at 4°C with mouse anti-Cd2 and rabbit anti-GFP (to detect tGPH) or rabbit anti-phosphoSer505-Akt, diluted in 1% ND/GS-T. The next day, fat bodies were washed in 1% ND/GS-T, incubated with goat anti-rabbit Alexa488 and donkey anti-mouse Cy3 secondary antibodies, diluted in 1% ND/GS-T, for 2 h at room temperature, counterstained with DAPI (Sigma-Aldrich), and mounted on slides in Fluoromount G (Electron Microscopy Sciences).
Western blot analysis
Whole larvae or adult flies (2/sample) or dissected fat bodies (6-10 pooled/sample) were sonicated in 2% SDS and 60 mM Tris-HCl, pH 6.8 with protease inhibitors (Roche Diagnostics) and phosphatase inhibitors. Equal amounts of protein (10-30 µg, measured by BCA assay, Pierce) were separated by SDS-PAGE, proteins were transferred to nitrocellulose, blocked in 3% milk in TBS with 0.1% Tween-20 (TBS-T), and blotted overnight at 4˚C with primary antibodies diluted in 1% milk in TBS-T. Following washes, blots were incubated with secondary antibodies in 1% milk in TBS-T, washed again, incubated with ECL (Pierce), and exposed to film. For phospho-specific antibodies, nitrocellulose membranes were blocked in 3% BSA in TBS-T, and blotted overnight at 4˚C with primary antibodies diluted in 1% BSA in TBS-T. Wash steps, secondary antibody incubation, and detection were performed as described above. Quantitative RT-PCR Total RNA was isolated from mid-third instar larval fat bodies (n = 6-8 pooled/sample) using the Reliaprep Tissue RNA Miniprep kit (Promega). Reverse transcription was performed on 1-2 µg total RNA using the ProtoScript First Strand cDNA Synthesis kit (New England Biolabs). Quantitative PCR reactions were performed on 20 ng cDNA, in triplicate, on a Bio-Rad CFX Connect Real-Time PCR Detection System using SYBR Select Master Mix (Life Technologies). Relative amounts of transcripts were calculated using the comparative C T method using Rp49 as a reference gene (Schmittgen and Livak, 2008) . Gene-specific primer sequences are listed on the next page.
Antibodies used in this study
Primers and oligonucleotides used in this study (all listed 5' to 3') Cloning primers, UAS-Akt-HA and UAS-Pdk1-myc:
Site-directed mutagenesis primers to generate Akt point mutants:
Primers for synthesis of Pdk1 gRNA: Pdk1-myc-gRNA-F CACCGACGTCACCTAGCAAGAAGA Pdk1-myc-gRNA-R AAACTCTTCTTGCTAGGTGACGTC T7-sgR-F TTAATACGACTCACTATAGGACGTCACCTAGCAAGAAGAGTTTTAGAGCTAGAAATAG T7-sgR-R AAAAGCACCGACTCGGTGCC ssDNA homology-directed repair template: AGCTTCGACGGCGTCTGACAACCGGACATTGGGTAGCACCAGAACGGGGACGTCACCTAGCAAGAAGACAACGTCTAAGA TGGAGCAGAAGCTGATCTCCGAGGAGGATCTGTAAATAACGTAGTCCTATTTATAGCAATGTGAAATTAATTTAGTTGAA ATTTAGTGCAAACGAAGCGATGGCGTAGAAGAGGGCGGGA Genotyping: Pdk1 myc allele generated with CRISPR/Cas9: Pdk1-myc-F1 ATGCTATCCACTGGTCGGAAG Pdk1-myc-R1 CCTAAGCACAATACAAATCGGA Pdk1-myc-R2 CTCGGAGATCAGCTTCT Primers for Q-PCR:
